Foundations in Continuing Education

The Dental Patient with Diabetes

Chapter Fourteen - Prevention and Treatment of DM


Chapter 1: Glucose Metabolism and Hormonal Regulation Review

Chapter 2: Diabetes Mellitus

Chapter 3: Diabetes Mellitus Type 1

Chapter 4: Diabetes Mellitus Type 2

Chapter 5: Gestational Diabetes Mellitus (GDM)

Chapter 6: Pre Diabetes: Impaired Glucose Homeostasis

Chapter 7: Other Specific Types of Diabetes

Chapter 8: Diagnosing Diabetes

Chapter 9: Diagnosis

Chapter 10: Glucose Monitoring

Chapter 11: Complications of Diabetes

Chapter 12: The Dental Patient with Diabetes

Chapter 13: Successful Intervention of Diabetic Emergencies

Introduction
Diet/Nutrition
Exercise
Pharmacological
Intervention

Administration
Method of Injection
Oral Hypoglycemic
Agents

Secretagogues
Biguanides (Metformin)
Thiazolidinediones
(Actos, Avandia)

Glucosidase Inhibitors
(Precose, Glyset)

Combination
Medications

Chapter 15: Diabetes Medications

Chapter 16: Conclusion

Glossary

Appendices

References

Post Examination

Exit to Menu





Biguanides (Metformin)

Biguanides were banned in the United States during the 1970's because they were linked to lactic acidosis. A safer biguanide, metformin, has been released (brand name Glucophage) and the risk of lactic acidosis appears to be minimal. This drug works through decreasing the amount of glucose released from the liver. This drug may also aid in weight reduction and improvement of lipid profiles. (25,28-30)

Continue on to Thiazolidinediones (Actos, Avandia)